A study of women undergoing breast imaging showed a significantly lower incidence of breast cancer in those who had a history ...
Biotech startup Immuneel Therapeutics announced a ₹100 Cr Series B fundraise from Singularity AMC, Rainmatter by Zerodha, ...
In " Beyond Diagnosis: Multiple Myeloma," Cleveland Clinic hematologist Sandra Mazzoni, DO, and host John Mangels continue ...
Medical professionals warn that if urgent action is not taken to enhance specialist capacity, the country’s growing blood ...
Conclusion: ATG-207 represents a differentiated immune tolerance–restoring strategy that integrates precision T cell ...
The new HCA Houston Healthcare Clear Lake opening will be the only blood cancer unit south of the Texas Medical Center, ...
SHANGHAI and HONG KONG, June 8, 2026 /PRNewswire/ -- Antengene Corporation Limited ('Antengene', SEHK: 6996.HK) , a leading ...
Vycellix to attend key upcoming investor & partnering events to share progress reports for its allogeneic cancer cell therapy ...
LB2102 demonstrated a manageable safety profile and encouraging clinical activity in solid tumors among heavily pretreated patients Responses ...
Eli Lilly and Company (NYSE: LLY) today announced the details of presentations at the European Hematology Association (EHA) ...
EHA 2026’s four-day hybrid program pairs plenary and presidential sessions with posters, reflecting the full spectrum from bench advances to real-world adoption and access barriers. Patient-centered ...
June events include USA trade mission to Norway (Oslo), the EHA Annual Meeting (Stockholm) and BIO International Convention (San Diego) Vycellix, Inc., a biotechnology company developing next-generati ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results